Dr. Ben Maruthappu
About Dr. Ben Maruthappu
Dr. Ben Maruthappu is the Founder and CEO of Cera and has held various significant roles in healthcare and academia. He has contributed to public health through initiatives like the NHS Diabetes Prevention Programme and has authored multiple medical publications and books.
Current Role at Cera
Dr. Ben Maruthappu serves as the Founder and CEO of Cera, a position he has held since 2016. Under his leadership, Cera has focused on improving health and care technology, aiming to enhance the quality of care provided to patients. His role involves strategic oversight and innovation in healthcare delivery.
Professional Experience
Dr. Maruthappu has extensive experience in various healthcare roles. He has been an Operating Partner at Kairos since 2017 and served as a Board Member at Kingdom Bank Ltd from 2021 to 2024. He was also a Board Member at Imperial College Healthcare NHS Trust from 2019 to 2022 and a Trustee & Board Member at Skills for Care from 2018 to 2023. Additionally, he co-founded the NHS Innovation Accelerator in 2015.
Education and Expertise
Dr. Maruthappu has a robust educational background in medicine and public health. He studied Medicine at the University of Oxford, earning a BM BCh, and completed a Master of Public Health at the London School of Hygiene and Tropical Medicine. He also holds a Kennedy Scholar in Health Policy from Harvard University and an MFPH from the Faculty of Public Health.
Research Contributions
Dr. Maruthappu has made significant contributions to medical research, with over 100 peer-reviewed publications in prestigious journals such as the Lancet and BMJ. His work has been recognized through his role as a peer-reviewer for the New England Journal of Medicine and the Lancet, reflecting his expertise in the field.
Recognition and Awards
Dr. Maruthappu has received several accolades for his contributions to healthcare. He was awarded an MBE in the Queen’s New Year’s Honours in 2020 for services to Health & Care technology. He has also been recognized in WIRED’s 10 Innovators in Healthcare and was the first from British healthcare to be included in Forbes’ 30 under 30 list.